Konstan, M. W., McKone, E. F., Moss, R. B., Marigowda, G., Tian, S., Waltz, D., Huang, X., Lubarsky, B., Rubin, J., Millar, S. J., Pasta, D. J., Mayer-Hamblett, N., Goss, C. H., Morgan, W., & Sawicki, G. S. (2017). assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study. Lancet, 5(2), 107–118. http://access.bl.uk/ark:/81055/vdc_100040922722.0x000010